Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03353350
What this trial is testing

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus
Hanmi Pharmaceutical Company Limited 406
Large-scale testing (Phase 3)Study completedNCT03170518
What this trial is testing

Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 171
Early research (Phase 1)Study completedNCT00511108
What this trial is testing

Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Merck Sharp & Dohme LLC 211
Early research (Phase 1)Study completedNCT06498284
What this trial is testing

Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type II
Hua Medicine Limited 40
Testing effectiveness (Phase 2)Study completedNCT01756716
What this trial is testing

Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR

Who this might be right for
Diabetic Nephropathy
Tanabe Pharma Corporation 49
Large-scale testing (Phase 3)Study completedNCT01103284
What this trial is testing

Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults

Who this might be right for
Type 1 Diabetes Mellitus
Andromeda Biotech Ltd. 475
Post-approval studies (Phase 4)Study completedNCT01526733
What this trial is testing

Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase

Who this might be right for
Type 1 Diabetes Mellitus
Halozyme Therapeutics 25
Testing effectiveness (Phase 2)Study completedNCT01496365
What this trial is testing

Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Who this might be right for
Diabetic Peripheral Neuropathy
Daiichi Sankyo 452
Early research (Phase 1)Study completedNCT04575181
What this trial is testing

A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 86
Large-scale testing (Phase 3)Ended earlyNCT00231634
What this trial is testing

The Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy

Who this might be right for
ObesityDiabetes Mellitus, Type 2Diabetes Mellitus, Adult-Onset
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 31
Testing effectiveness (Phase 2)Study completedNCT06851858
What this trial is testing

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

Who this might be right for
EndocrinologyDiabetes, Type IIObesity
AstraZeneca 69
Not applicableNot Yet RecruitingNCT07570810
What this trial is testing

Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM

Who this might be right for
Type 2 DiabetesObesityNon-alcoholic Fatty Liver Disease
Shanghai Jiao Tong University School of Medicine 30
Large-scale testing (Phase 3)Study completedNCT00390520
What this trial is testing

Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 28
Early research (Phase 1)Looking for participantsNCT07473323
What this trial is testing

Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease

Who this might be right for
Healthy Adult ParticipantsDiabetic Kidney Disease
Mediar Therapeutics 88
Post-approval studies (Phase 4)WithdrawnNCT00265746
What this trial is testing

Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Medical University of Lodz
Large-scale testing (Phase 3)UnknownNCT02477969
What this trial is testing

Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Jiangsu Hansoh Pharmaceutical Co., Ltd. 587
Post-approval studies (Phase 4)Study completedNCT00120341
What this trial is testing

Anodyne Therapy in Diabetic Sensory Neuropathy

Who this might be right for
Diabetes MellitusDiabetic Neuropathy
Scott and White Hospital & Clinic 60
Post-approval studies (Phase 4)Study completedNCT05293041
What this trial is testing

Argipressin's Influence on Blood Loss During Hepatic Resection

Who this might be right for
Colon Cancer Liver MetastasisInflammatory ResponseVasopressin Causing Adverse Effects in Therapeutic Use
Kristina Svennerholm 248
Large-scale testing (Phase 3)Study completedNCT00094770
What this trial is testing

An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 1,172
Large-scale testing (Phase 3)Study completedNCT04809220
What this trial is testing

Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders+4 more
Eli Lilly and Company 591
Next Page